MedTrace Logo

A Study to Investigate the Anti-Plaque Effect of AN0128 Toothpaste

NCT00762151 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 18

Last updated 2019-06-05

No results posted yet for this study

Summary

The objective of this study was to evaluate the anti-plaque efficacy of the Anacor prototype dentrifice as compared to commercial control products following a single use of the dentrifice.

Conditions

  • Dental Plaque

Interventions

OTHER

Negative Control (Regular Toothpaste)

Regular Toothpaste

OTHER

Positive Control (anti-plaque/anti-bacterial toothpaste)

Standard anti-plaque and anti-bacterial toothpaste

DRUG

Prototype (AN0128 Toothpaste)

AN0128 Toothpaste

Sponsors & Collaborators

Principal Investigators

  • Pfizer CT.gov Call Center · Pfizer

Study Design

Purpose
PREVENTION
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-11-30
Primary Completion
2008-01-31
Completion
2008-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00762151 on ClinicalTrials.gov